Follow
james m. Olson
Title
Cited by
Cited by
Year
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy, P Tamayo, M Gaasenbeek, LM Sturla, M Angelo, ...
Nature 415 (6870), 436-442, 2002
27122002
Medulloblastoma growth inhibition by hedgehog pathway blockade
DM Berman, SS Karhadkar, AR Hallahan, JI Pritchard, CG Eberhart, ...
Science 297 (5586), 1559-1561, 2002
10012002
Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease
R Luthi-Carter, A Strand, NL Peters, SM Solano, ZR Hollingsworth, ...
Human molecular genetics 9 (9), 1259-1271, 2000
8372000
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges, AD Strand, AK Aragaki, A Kuhn, T Sengstag, G Hughes, ...
Human molecular genetics 15 (6), 965-977, 2006
8232006
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ...
Nature 488 (7409), 49-56, 2012
8182012
Intertumoral heterogeneity within medulloblastoma subgroups
FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ...
Cancer cell 31 (6), 737-754. e6, 2017
7462017
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
YJ Cho, A Tsherniak, P Tamayo, S Santagata, A Ligon, H Greulich, ...
Journal of Clinical Oncology 29 (11), 1424, 2011
7292011
Generation of neurons by transient expression of neural bHLH proteins in mammalian cells
MH Farah, JM Olson, HB Sucic, RI Hume, SJ Tapscott, DL Turner
Development 127 (4), 693-702, 2000
5662000
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
AR Hallahan, JI Pritchard, S Hansen, M Benson, J Stoeck, BA Hatton, ...
Cancer research 64 (21), 7794-7800, 2004
5652004
Huntingtin interacting proteins are genetic modifiers of neurodegeneration
LS Kaltenbach, E Romero, RR Becklin, R Chettier, R Bell, A Phansalkar, ...
PLoS genetics 3 (5), e82, 2007
4792007
Tumor paint: a chlorotoxin: Cy5. 5 bioconjugate for intraoperative visualization of cancer foci
M Veiseh, P Gabikian, SB Bahrami, O Veiseh, M Zhang, RC Hackman, ...
Cancer research 67 (14), 6882-6888, 2007
4702007
Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-and kainate-sensitive glutamate binding sites.
JT Greenamyre, JM Olson, JB Penney, AB Young
Journal of Pharmacology and Experimental Therapeutics 233 (1), 254-263, 1985
4631985
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
R Luthi-Carter, SA Hanson, AD Strand, DA Bergstrom, W Chun, NL Peters, ...
Human molecular genetics 11 (17), 1911-1926, 2002
4382002
An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles
JG Thomas, JM Olson, SJ Tapscott, LP Zhao
Genome Research 11 (7), 1227-1236, 2001
4232001
PEI–PEG–chitosan‐copolymer‐coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection
FM Kievit, O Veiseh, N Bhattarai, C Fang, JW Gunn, D Lee, ...
Advanced functional materials 19 (14), 2244-2251, 2009
4112009
p38 MAP kinase: a convergence point in cancer therapy
JM Olson, AR Hallahan
Trends in molecular medicine 10 (3), 125-129, 2004
3892004
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin …
A Kuhn, DR Goldstein, A Hodges, AD Strand, T Sengstag, C Kooperberg, ...
Human molecular genetics 16 (15), 1845-1861, 2007
3772007
Design of highly emissive polymer dot bioconjugates for in vivo tumor targeting
C Wu, SJ Hansen, Q Hou, J Yu, M Zeigler, Y Jin, DR Burnham, JD McNeill, ...
Angewandte Chemie 123 (15), 3492-3496, 2011
3662011
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma
BS Paugh, A Broniscer, C Qu, CP Miller, J Zhang, RG Tatevossian, ...
Journal of clinical oncology 29 (30), 3999, 2011
3062011
Accurate de novo design of hyperstable constrained peptides
G Bhardwaj, VK Mulligan, CD Bahl, JM Gilmore, PJ Harvey, O Cheneval, ...
Nature 538 (7625), 329-335, 2016
2992016
The system can't perform the operation now. Try again later.
Articles 1–20